Key Insights

Highlights

Treatment Research

1 treatments under study, led by Sonocloud 9 Transducers

Research Leaders

6 sponsors active, led by Assistance Publique Hopitaux De Paris

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05293197Phase 1Recruiting

Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients

Showing all 1 trials

Research Network

Common Treatments

  • Sonocloud 9 Transducers1

Active Sponsors

  • Assistance Publique Hopitaux De Paris1
  • Assistance Publique - Hôpitaux de Paris1
  • CarThera1
  • Gustave Roussy, Cancer Campus, Grand Paris1
  • Institut Curie1

Top Investigators

Related Conditions

  • Embryonal Tumor1
  • Malignant Brain Tumor1
  • Malignant Glioma1

Activity Timeline